{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:22:45Z","timestamp":1791256965878,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ministry of Culture, Sports, Science and Technology","award":["15K08394"],"award-info":[{"award-number":["15K08394"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.pathol.2016.02.003","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T16:31:58Z","timestamp":1457368318000},"page":"233-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Role of microRNA-29b in myelodysplastic syndromes during transformation to overt leukaemia"],"prefix":"10.1016","volume":"48","author":[{"given":"Susumu","family":"Kirimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morito","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iichiroh","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Abe-Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouhei","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2016.02.003_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2016.02.003_bib2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJMp048266","article-title":"Myelodysplastic syndromes\u2014coping with ineffective hematopoiesis","volume":"352","author":"Cazzola","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2016.02.003_bib3","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.4161\/cc.6.17.4641","article-title":"MicroRNAs and cell cycle regulation","volume":"6","author":"Carleton","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.pathol.2016.02.003_bib4","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.1065062","article-title":"An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans","volume":"294","author":"Lau","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pathol.2016.02.003_bib5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.gde.2005.06.012","article-title":"MicroRNAs in vertebrate development","volume":"15","author":"Harfe","year":"2005","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.pathol.2016.02.003_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2016.02.003_bib7","doi-asserted-by":"crossref","first-page":"20930","DOI":"10.3390\/ijms141020930","article-title":"MicroRNA-regulated pathways in hematological malignancies: how to avoid cells playing out of tune","volume":"14","author":"Fatica","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pathol.2016.02.003_bib8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4161\/epi.24897","article-title":"Epigenetic alterations and microRNAs: new players in the pathogenesis of myelodysplastic syndromes","volume":"8","author":"Vasilatou","year":"2013","journal-title":"Epigenetics"},{"key":"10.1016\/j.pathol.2016.02.003_bib9","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3324\/haematol.2011.054437","article-title":"Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients","volume":"97","author":"Santamar\u00eda","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2016.02.003_bib10","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2016.02.003_bib11","first-page":"1930","article-title":"Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases","volume":"88","author":"Le Beau","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2016.02.003_bib12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2141.1996.d01-2683.x","article-title":"Deletions of the long arm of chromosome 7 in myeloid disorders: loss of band 7q32 implies worst prognosis","volume":"92","author":"Velloso","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2016.02.003_bib13","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1038\/sj.onc.1210436","article-title":"mir-29 regulates Mcl-1 protein expression and apoptosis","volume":"26","author":"Mott","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.pathol.2016.02.003_bib14","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/hep.23380","article-title":"Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma","volume":"51","author":"Xiong","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.pathol.2016.02.003_bib15","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1182\/blood-2010-09-301994","article-title":"MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression","volume":"117","author":"Desjobert","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2016.02.003_bib16","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1182\/blood-2009-03-211938","article-title":"MicroRNA 29b functions in acute myeloid leukemia","volume":"114","author":"Garzon","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2016.02.003_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0968-0004(00)01740-0","article-title":"Life-or-death decisions by the Bcl-2 protein family","volume":"26","author":"Adams","year":"2001","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.pathol.2016.02.003_bib18","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/sj.leu.2402416","article-title":"MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis","volume":"16","author":"Craig","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2016.02.003_bib19","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood.V89.2.630","article-title":"Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions","volume":"89","author":"Zhou","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2016.02.003_bib20","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1038\/sj.leu.2403180","article-title":"Expression of FLIP(Long) and FLIP(Short) in bone marrow mononuclear and CD34+ cells in patients with myelodysplastic syndrome: correlation with apoptosis","volume":"17","author":"Benesch","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2016.02.003_bib21","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2016.02.003_bib22","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1210\/jcem.87.7.8644","article-title":"Developmental changes in expression of myeloid cell leukemia-1 in human germ cells during oogenesis and early folliculogenesis","volume":"87","author":"Hartley","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2016.02.003_bib23","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1073\/pnas.90.8.3516","article-title":"MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2","volume":"90","author":"Kozopas","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2016.02.003_bib24","doi-asserted-by":"crossref","first-page":"25255","DOI":"10.1074\/jbc.M909826199","article-title":"MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain","volume":"275","author":"Bae","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2016.02.003_bib25","doi-asserted-by":"crossref","first-page":"22136","DOI":"10.1074\/jbc.M909572199","article-title":"Exon skipping in Mcl-1 results in a bcl-2 homology domain 3 only gene product that promotes cell death","volume":"275","author":"Bingle","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2016.02.003_bib26","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.febslet.2009.08.006","article-title":"MCL-1ES, a novel variant of MCL-1, associates with MCL-1L and induces mitochondrial cell death","volume":"583","author":"Kim","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pathol.2016.02.003_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.1136235","article-title":"A\u00a0hexanucleotide element directs microRNA nuclear import","volume":"315","author":"Hwang","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.pathol.2016.02.003_bib28","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1007\/s00018-008-8637-6","article-title":"Mcl-1 is a potential therapeutic target in multiple types of cancer","volume":"66","author":"Akgul","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pathol.2016.02.003_bib29","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0301-472X(00)00527-0","article-title":"Alteration of c-mpl-mediated signal transduction in CD34(+) cells from patients with myelodysplastic syndromes","volume":"28","author":"Kalina","year":"2000","journal-title":"Exp Hematol"},{"key":"10.1016\/j.pathol.2016.02.003_bib30","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1182\/blood.V89.5.1690","article-title":"Erythropoietin-induced activation of STAT5 is impaired in the myelodysplastic syndrome","volume":"89","author":"Hoefsloot","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2016.02.003_bib31","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3324\/haematol.2012.070664","article-title":"MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation","volume":"98","author":"Pigazzi","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2016.02.003_bib32","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1751-553X.2008.01056.x","article-title":"CD34, RAB20, PU.1 and GFI1 mRNA expression in myelodysplastic syndrome","volume":"31","author":"Huh","year":"2009","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.pathol.2016.02.003_bib33","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1101\/gad.1522007","article-title":"NBK\/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition","volume":"21","author":"Shimazu","year":"2007","journal-title":"Genes Dev"},{"key":"10.1016\/j.pathol.2016.02.003_bib34","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1101\/gad.1304105","article-title":"Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins","volume":"19","author":"Willis","year":"2005","journal-title":"Genes Dev"},{"key":"10.1016\/j.pathol.2016.02.003_bib35","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/ncb1499","article-title":"Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies","volume":"8","author":"Kim","year":"2006","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.pathol.2016.02.003_bib36","doi-asserted-by":"crossref","first-page":"35217","DOI":"10.1074\/jbc.M506551200","article-title":"Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation","volume":"280","author":"Rahmani","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2016.02.003_bib37","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1158\/0008-5472.CAN-07-0598","article-title":"The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation","volume":"67","author":"Rosato","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2016.02.003_bib38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbrc.2011.09.063","article-title":"Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1","volume":"414","author":"Zhang","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pathol.2016.02.003_bib39","doi-asserted-by":"crossref","first-page":"32233","DOI":"10.1074\/jbc.M706408200","article-title":"The N terminus of the anti-apoptotic BCL-2 homologue MCL-1 regulates its localization and function","volume":"282","author":"Germain","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2016.02.003_bib40","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1042\/BJ20041596","article-title":"A\u00a0proteolytic fragment of Mcl-1 exhibits nuclear localization and regulates cell growth by interaction with Cdk1","volume":"387","author":"Jamil","year":"2005","journal-title":"Biochem J"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516000635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516000635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:21:34Z","timestamp":1758471694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516000635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0031302516000635"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2016.02.003","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of microRNA-29b in myelodysplastic syndromes during transformation to overt leukaemia","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2016.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}